Effect of core stability exercise in treatment of iliotibial band syndrome
Not Applicable
- Conditions
- Iliotibial band syndromeIliotibial Band Syndrome.M76.3
- Registration Number
- IRCT20200211046456N1
- Lead Sponsor
- The University of Lahore
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
The age between 18-50 years in both the gender
Presence of local tenderness over the lateral epicondyle
Subjects with Positive Noble compression test
Subjects with Positive modified ober’s test
Exclusion Criteria
Systemic illness
Peripheral nerve involvement in lower extremity
Any type of Arthritis of lower limb
Tumor
History of previous knee trauma and surgery
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: At baseline (before intervention), 3 weeks of treatment and at end of treatment (6 weeks). Method of measurement: Numeric Pain Rating Scale.;Functional Mobility. Timepoint: At baseline (before intervention), 3 weeks of treatment and at end of treatment (6 weeks). Method of measurement: Lower Extremity Functional Scale.
- Secondary Outcome Measures
Name Time Method Quality of Life. Timepoint: At baseline (before intervention) and at end of treatment (6 weeks). Method of measurement: Short Form (36) Health Survey.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link core stability exercises to pain reduction in iliotibial band syndrome (M76.3)?
How does core stability training compare to standard physical therapy for ITBS in functional mobility outcomes?
Are there specific biomarkers like gait kinematics or muscle activation patterns predicting response to core stability interventions in ITBS?
What adverse events are associated with core stability protocols in ITBS treatment, and how are they managed?
What combination therapies with orthotic devices or pharmacological agents enhance core stability outcomes for ITBS patients?